---
figid: PMC2677695__halms367501f2
figtitle: Targeting the AMPK pathway for the treatment of Type 2 diabetes
organisms:
- NA
pmcid: PMC2677695
filename: halms367501f2.jpg
figlink: /pmc/articles/PMC2677695/figure/F2/
number: F2
caption: AMPK is activated by phosphorylation of Thr 172 catalysed by LKB1:STRAD:MO25
  complex in response to increase in the AMP/ATP ratio and by CaMKKβ in response to
  elevated Ca2+ levels. Thr172 is dephosphorylated by PP2C protein phosphatase switching
  active AMPK to the inactive form.
papertitle: Targeting the AMPK pathway for the treatment of Type 2 diabetes.
reftext: Benoît Viollet, et al. Front Biosci (Landmark Ed). ;14:3380-3400.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9410515
figid_alias: PMC2677695__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC2677695__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2677695__halms367501f2.html
  '@type': Dataset
  description: AMPK is activated by phosphorylation of Thr 172 catalysed by LKB1:STRAD:MO25
    complex in response to increase in the AMP/ATP ratio and by CaMKKβ in response
    to elevated Ca2+ levels. Thr172 is dephosphorylated by PP2C protein phosphatase
    switching active AMPK to the inactive form.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATPsynbeta
  - Atpalpha
  - Mo25
  - Lkb1
  - Amph
  - adp
  - pi
  - Pp2C1
  - CG17598
  - CG7115
  - CG10376
  - Phlpp
  - Ppm1
  - CG17746
  - Thr
---
